GHPharm


Korean company focused on research, development and commercialization of natural-product formulations derived from fern root/rhizome extracts. Documented activities include extraction and detoxification of plant material, isolation and characterization of small-molecule derivatives, in vitro antiviral screening, enzyme-inhibition and blood–brain barrier studies relevant to neurodegeneration, rodent efficacy models including hair-growth studies, analytical verification of toxin removal, patent filing, academic collaborations, and development and sale of liquid single-dose supplement/beverage formulations. Several peer-reviewed publications and patent filings are cited in site press material.

Industries

pharmaceutical
retail

GHPharm

Seoul, Seoul-t'ukpyolsi, South Korea, Asia


Products

Pterosin-derivative liquid supplement (single-dose sachets; beverage formulations)

Liquid oral supplement formulated from processed fern root/rhizome extracts containing identified small-molecule derivatives; offered in 70 ml single-dose sachets, with sugar-free variants and related beverage/tea formulations described in site materials.


Services

Research collaborations with academic and public research centers

Joint preclinical and early translational research projects with university laboratories and regional bio centers.

Expertise Areas

  • Natural product extraction and small-molecule isolation
  • Preclinical in vivo efficacy testing (rodent hair-growth models)
  • In vitro antiviral and cell-based screening
  • Enzyme inhibition profiling for neurodegeneration targets
  • Show More (4)

Key Technologies

  • Small-molecule natural product isolation and purification
  • In vitro cell-based antiviral assays (Vero cells)
  • Enzyme inhibition assays (including BACE1 and cholinesterases)
  • Rodent in vivo efficacy models (hair-growth assays)
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.